Oxidative cyclization of N-acylhydrazones. Development of highly selective turn-on fluorescent chemodosimeters for Cu2+

Ai-Fang Li , Hui He , Yi-Bin Ruan , Zhen-Chang Wen , Jin-Song Zhao , Qiu-Ju Jiang and Yun-Bao Jiang *
Department of Chemistry, College of Chemistry and Chemical Engineering and the MOE Key Laboratory of Analytical Sciences, Xiamen University, Xiamen 361005, China. E-mail: ybjiang@xmu.edu.cn; Fax: (+86)592-218-5662; Tel: (+86)592-218-5662

Received 8th July 2008 , Accepted 10th October 2008

First published on 10th November 2008


Abstract

A series of N-acylhydrazones were synthesised and found to be “turn-on” fluorescent chemodosimeters for Cu2+. Among the tested transition metal ions such as Cu2+, Pb2+, Zn2+, Cd2+, Hg2+, and Ni2+, a prominent fluorescence enhancement of up to 1000-fold was only observed for Cu2+ in acetonitrile (CH3CN). This was indicated by an onset of unprecedented structured emission. Detailed experiments established that the highly Cu2+ selective fluorescence enhancement resulted from an oxidative cyclization by Cu2+of the originally nonfluorescent N-acylhydrazones into highly fluorescent rigid 1,3,4-oxadiazoles, n-dope type blocks in optoelectronic materials. The chemodosimeters can be applied to sense Cu2+ at nM levels in CH3CN and sub-µM levels in neutral aqueous environments, despite a slower response in the latter case. It is expected that these redox-based chemodosimeters might be of general applicability.


Introduction

N-Acylhydrazones have been widely employed in organic1 and analytical2 chemistry, mainly in terms of metal ligands.2,3 It is known that N-acylhydrazones coordinate strongly with a variety of transition metal ions, forming complexes of varied biological and pharmaceutical activities. The development of sensitive and selective fluorescent chemosensors for biologically important metal ions is of intense current interest because these metal ions play important roles in living and environmental systems.4 Special attention has been focused on the design of fluorescent chemosensors for Cu2+ due to its essential yet toxic nature.5 We previously found that N-(p-dimethylaminobenzoyl)hydrazone (1, Scheme 1), bearing an intramolecular charge transfer (ICT) fluorophore, p-dimethylaminobenzamide, showed a highly selective fluorescence response toward Cu2+ in CH3CN, despite similar absorption spectral variations being observed with other metal ions such as Pb2+, Zn2+, and Hg2+ too.6 This finding suggested that the N-acylhydrazone in this case might act not only as a ligand. Although several explanations were proposed, the exact mechanism, however, could not be clarified with just one molecule that also bears complicated excited-state ICT photophysics.6 In order to understand the responding mechanism, we decided to remove the ICT channel in 1 to simplify the excited-state photophysics and data rationalization. We therefore extended our investigation to a variety of N-benzoylhydrazones 2 and 3 bearing substituents X less electron-donating than p-NMe2 in 1 (Scheme 1). A highly selective fluorescence response toward Cu2+ was again observed in both CH3CN and CH3CN–H2O solutions. In particular, the observed enhanced emission is unprecedentedly structured in these polar solvents. Detailed experiments allowed us to establish that the enhanced fluorescence was due to an oxidative cyclization by Cu2+ of the originally nonfluorescent N-acylhydrazones into highly fluorescent rigid 1,3,4-oxadiazoles. N-Acylhydrazones were therefore shown to be a kind of redox-based “turn-on” fluorescent chemodosimeter for Cu2+, a new entrance to the active subject of “turn-on” fluorescent chemosensors for Cu2+, a strongly quenching paramagnetic species.7–9 It should be pointed out that there have been several nice Cu2+ chemodosimeters with enhanced fluorescence signal outputs, which however follow hydrolysis8 or rearrangement reactions.9
Molecular structures of N-acylhydrazones 1–4.
Scheme 1 Molecular structures of N-acylhydrazones 1–4.

Results and discussion

N-Acylhydrazones 2 and 3 were facilely synthesized by a simple one-step reaction in ethanol of the corresponding N-benzoylhydrazine with 2-methoxybenzaldehyde and furan-2-carbaldehyde, respectively. 2a in CH3CN exhibits three absorption bands centred at 287, 298, and 323 nm with respective molar absorption coefficients of 2.67 × 104, 2.59 × 104, and 2.93 × 104 M−1 cm−1, indicative of the (π, π*) transition character. In the presence of Cu2+, the band at 323 nm is attenuated and a shoulder at ca. 365 nm is developed (Fig. 1a). Hg2+ and Pb2+ exert a similar effect, whereas other heavy transition metal ions such as Zn2+, Cd2+, and Ni2+ exert a minor influence on the absorption spectrum. 2b–d behave similarly in their absorption spectral response toward these metal ions (Fig. S1-S4). 3, analogues of 2, exhibit spectral variation profiles (Fig. S5-S8) similar to those of 2. 2 and 3 in CH3CN emit extremely weak fluorescence. In the presence of Cu2+, however, an instant response was observed by a dramatic enhancement of up to 1000-fold, despite the well-known quenching character of Cu2+ (Fig. 1b, 2, S9, and S10). The fluorescence response profiles of 2 and 3 toward Cu2+ were found to be simpler than that of 1,6 in that there was no emission band shift and no fluorescence quenching at higher Cu2+ concentration with 2 and 3 (Fig. 2). Removing the excited-state ICT channel in 1, much higher fluorescence enhancement for 2a and 3a by Cu2+ was observed (Fig. 2) than that for 1 which was ca.180-fold.6 Assays of the fluorescence response of 2 and 3 in CH3CN toward a variety of other transition metal ions such as Pb2+, Zn2+, Cd2+, Hg2+, and Ni2+ indicated that a prominent fluorescence enhancement was again only observed for Cu2+ whereas the other transition metal ions tested exerted little influence (Fig. 2). This means that the fluorescence responses of 2 and 3 are highly selective for Cu2+, as is 1.6 The fluorescence enhancement factors (FEFs) of 2 and 3 by Cu2+ were found to be higher with increasing electron-donating ability of the substituent X and the FEFs of 3 were much higher than those of 2 (Fig. 2 and Table 1). It therefore appears that higher electron density at the hydrazone moiety and the relatively more exposed furan oxygen atom in 3 are important for higher FEFs. The fact that the fluorescence in CH3CN of 4 (Scheme 1), a control molecule for 3a, does not show any response toward Cu2+, despite a substantial absorption variation (Fig. 3), nicely indicates that the vinyl proton [double bond, length as m-dash]CH in 3a plays an essential role in the fluorescence enhancement of 3a by Cu2+.
Absorption (a) and fluorescence (b) spectra of 2a (20 µM) in CH3CN in the presence of increasing concentrations of Cu2+ (0–200 µM). The excitation wavelength was 267 nm, an isosbestic wavelength observed in absorption titrations.
Fig. 1 Absorption (a) and fluorescence (b) spectra of 2a (20 µM) in CH3CN in the presence of increasing concentrations of Cu2+ (0–200 µM). The excitation wavelength was 267 nm, an isosbestic wavelength observed in absorption titrations.

Plots of fluorescence enhancement factor (FEF, I/I0) in CH3CN versus concentration ratio of metal ion to 2 and 3. R = 2a–d or 3a–d, [2] = [3] = 10 µM.
Fig. 2 Plots of fluorescence enhancement factor (FEF, I/I0) in CH3CN versus concentration ratio of metal ion to 2 and 3. R = 2a–d or 3a–d, [2] = [3] = 10 µM.
Table 1 Absorption and fluorescence spectral parameters of 2 and 3, and 2 and 3 in the presence of 25 equivalents of metal ion in CH3CN
  λ abs/nm ε/104 M−1 cm−1 λ flu/nm FEF a Φb
a Fluorescence enhancement factor, the ratio of the intensity of 2 and 3 in the presence of 25 equivalents of metal ion to that in the absence of metal ion. b Fluorescence quantum yields of 2 and 3, and 2 and 3 in the presence of 25 equivalents of metal ion were measured using quinine sulfate as a standard (0.546 in 0.5 M H2SO4: Demas, J. N.; Crobys, G. A., J. Phys. Chem.1971, 75, 991–1024). The measurement errors were up to 50% and 15% for N-acylhydrazones and their metal complexes, respectively.
2a 287/298/323 2.67/2.59/2.93 369 0.0007
2a + Ni2+ 365 0.32 364 1.9 0.0008
2a + Cu2+ 365 0.50 358 280 0.34
2a + Zn2+ 365 0.10 360 5.7 0.0013
2a + Cd2+ 364 0.08 367 1.4 0.0009
2a + Hg2+ 368 0.56 364 1.5 0.0025
2a + Pb2+ 375 0.26 364 1.4 0.0012
2b 286/297/323 2.12/2.10/2.50 370 0.0008
2b + Ni2+ 365 0.25 358 1.1 0.0010
2b + Cu2+ 368 0.33 351 140 0.30
2b + Zn2+ 365 0.10 353 5.7 0.0013
2b + Cd2+ 366 0.04 370 1.1 0.0010
2b + Hg2+ 372 0.40 357 2.4 0.0018
2b + Pb2+ 375 0.39 355 1.4 0.0011
2c 286/298/323 1.92/1.92/2.37 370 0.0007
2c + Ni2+ 364 0.20 358 1.1 0.0011
2c + Cu2+ 370 0.30 355 55 0.20
2c + Zn2+ 364 0.05 358 1.9 0.0027
2c + Cd2+ 364 0.05 370 2.2 0.0012
2c + Hg2+ 361 0.47 357 1.7 0.0024
2c + Pb2+ 375 0.50 357 1.3 0.0015
2d 287/299/324 1.74/1.71/2.10 370 0.0008
2d + Ni2+ 364 0.23 364 1.1 0.0010
2d + Cu2+ 365 0.41 362 80 0.26
2d + Zn2+ 366 0.10 364 1.9 0.0014
2d + Cd2+ 367 0.03 373 2.2 0.0011
2d + Hg2+ 364 0.50 363 1.7 0.0042
2d + Pb2+ 375 0.75 364 1.3 0.0015
3a 254/310 1.01/3.75 370 0.0004
3a + Ni2+ 315/378 2.94/0.51 367 1.4 0.0016
3a + Cu2+ 296/345 2.66/1.55 366 1000 0.49
3a + Zn2+ 326 3.76 365 5.2 0.0038
3a + Cd2+ 328 4.06 381 1.5 0.0024
3a + Hg2+ 338 4.15 368 29 0.0032
3a + Pb2+ 333 3.69 367 1.1 0.0034
3b 238/308 1.02/3.37 371 0.0004
3b + Ni2+ 310/365 3.10/0.23 358 1.1 0.0032
3b + Cu2+ 327 1.71 361 260 0.36
3b + Zn2+ 313 3.23 364 1.3 0.0018
3b + Cd2+ 319 3.31 379 1.1 0.0025
3b + Hg2+ 333 3.43 364 8.1 0.0047
3b + Pb2+ 330 3.22 366 1.1 0.0025
3c 228/308 0.94/3.01 370 0.0005
3c + Ni2+ 309/365 3.03/0.24 372 1.1 0.0029
3c + Cu2+ 319 1.01 360 145 0.33
3c + Zn2+ 311 2.87 372 1.2 0.0030
3c + Cd2+ 314 2.95 385 1.1 0.0007
3c + Hg2+ 332 3.07 365 6.3 0.0047
3c + Pb2+ 330 2.74 366 1.1 0.0038
3d 236/309 1.27/3.26 371 0.0004
3d + Ni2+ 310/371 2.92/0.29 370 1.1 0.0024
3d + Cu2+ 319/376 1.31/0.12 368 136 0.29
3d + Zn2+ 311/374 3.11/0.06 369 1.0 0.0017
3d + Cd2+ 314 3.15 396 1.0 0.0010
3d + Hg2+ 334/390 3.11/0.18 371 2.9 0.0039
3d + Pb2+ 332 2.88 372 1.1 0.0026




          Absorption spectra of 4 (10 µM) in CH3CN in the presence of increasing concentrations of Cu2+ (0–200 µM). The excitation wavelength for acquiring fluorescence spectra given in the inset is an isosbestic wavelength of 274 nm.
Fig. 3 Absorption spectra of 4 (10 µM) in CH3CN in the presence of increasing concentrations of Cu2+ (0–200 µM). The excitation wavelength for acquiring fluorescence spectra given in the inset is an isosbestic wavelength of 274 nm.

It was surprising that an unexpected structured emission was observed for 2 and 3 in the presence of Cu2+ (Fig. 1b and 4 ). The trend shown in Fig. 4, that the emission becomes less structured while the FEF becomes lower with decreasing electron-donating ability of the substituent X, seems to suggest that the FEF value is related to the structured extent of the fluorescence spectrum. In order to test this correlation, an extended variety of N-acylhydrazones (5–12, Scheme 2) were prepared and their fluorescence response toward Cu2+ was monitored in CH3CN. The fluorescence of 5–12 was similarly found to be enhanced by Cu2+, confirming that N-acylhydrazones could in general act as an excellent family of “chemosensors” for Cu2+. The structured extents of the emission spectra and the FEF values shown in Fig. 5, however, indicate that the apparent correlation between the structured extents and the FEF values reached in Fig. 4 does not hold in general, the rigidity of the ligand itself obviously contributing to the structured extent of the final emission spectrum. The unexpected structured emission and the high selectivity for Cu2+ therefore could not be simply attributed to Cu2+ coordination to N-acylhydrazones.


Normalized fluorescence spectra of 2 and 3 in the presence of 25 equivalents of Cu2+ in CH3CN at 25 °C.
Fig. 4 Normalized fluorescence spectra of 2 and 3 in the presence of 25 equivalents of Cu2+ in CH3CN at 25 °C.

Normalized fluorescence spectra of 2c and 5–12 and FEF values in the presence of 25 equivalents of Cu2+ in CH3CN at 25 °C.
Fig. 5 Normalized fluorescence spectra of 2c and 5–12 and FEF values in the presence of 25 equivalents of Cu2+ in CH3CN at 25 °C.

Structures of the extended variety of N-acylhydrazones.
Scheme 2 Structures of the extended variety of N-acylhydrazones.

The fluorescence emission of a ligand can in principle be affected not only by metal ion coordination, but by a metal ion involved reaction as well.10 The fact that the enhancement by Cu2+ of the fluorescence of 2 and 3 becomes higher when the substituent X is more electron-donating suggested that a redox reaction might occur. Indeed, it was reported that N-acylhydrazones underwent oxidative cyclization to 1,3,4-oxadiazoles by several oxidants.11 Cu(ClO4)2 in CH3CN could be an effective oxidant, since the Cu2+/Cu+ couple in CH3CN reportedly has a high reduction potential due to the stabilization of Cu+ by solvent coordination.12 We therefore hypothesized that Cu2+ acted as an oxidant in CH3CN to result in an oxidative cyclization of N-acylhydrazones into 1,3,4-oxadiazoles. As no credible signals were detected in the cyclic voltammograms of the reported N-acylhydrazones in CH3CN, we were unable to directly confirm this hypothesis on the basis of redox potentials data. Alternatively, crucial evidence supporting this hypothesis was obtained from the independent syntheses of 1,3,4-oxadiazoles by reactions of N-acylhydrazones 3 with Cu(ClO4)2 in CH3CN. The oxidative cyclization products 1,3,4-oxadiazoles 13 (Scheme 3, Table S1) were fully characterized by HRMS, 1H NMR, and 13C NMR. Fluorescence excitation and emission spectra of the synthesized oxidative cyclization product 13a were found identical to those of 3a in the presence of 1.0 equivalent of Cu2+ (Fig. S11). Obviously the observed fluorescence enhancement of 3a by Cu2+ was not caused by Cu2+ coordination but instead by the oxidative cyclization reaction. In order to confirm the role of Cu2+ in the reaction of N-acylhydrazones in CH3CN, EPR experiments in CH3CN at 100 K were carried out in which the Cu2+ concentration was made constant while the 3a concentration varied. It was found that the EPR signal of Cu2+ was indeed attenuated with increasing 3a concentration (Fig. 6). This points to the conversion of Cu2+ into diamagnetic Cu+ that can be stabilized in CH3CN. A mechanism of the oxidative cyclization by Cu2+ was therefore suggested (Scheme 3), which forms the basis of this new kind of redox-based chemodosimeter for Cu2+.



          EPR spectra of 1.0 mM Cu2+ in CH3CN at 100 K with increasing concentration of 3a.
Fig. 6 EPR spectra of 1.0 mM Cu2+ in CH3CN at 100 K with increasing concentration of 3a.

Proposed oxidative cyclization of N-acylhydrazones by Cu2+ in CH3CN.
Scheme 3 Proposed oxidative cyclization of N-acylhydrazones by Cu2+ in CH3CN.

The absorption and fluorescence spectra of the oxidative cyclization product 13a in CH3CN, hardly changed upon the addition of up to 25 equivalents Cu2+ (Fig. S12). This explained the observed level-off of FEFs of 2 and 3 at higher Cu2+ concentration (Fig. 2). The observation that the absorption spectrum of 4 in CH3CN undergoes substantial variation whereas it remains nonfluorescent in the presence of Cu2+ (Fig. 3) suggests that a simple coordination of Cu2+ to N-acylhydrazones in the ground state does not lead to an enhancement in the fluorescence of N-acylhydrazones. It was found that the fluorescence quantum yield of 13a (Φ = 0.725) in CH3CN is ca.1800-fold that of 3a (Φ = 4 × 10−4). It is hence made clear that the dramatic fluorescence enhancement results fully from the oxidative cyclization by Cu2+ in CH3CN of the nonfluorescent N-acylhydrazones which leads to the highly fluorescent rigid 1,3,4-oxadiazoles. The fluorescence response selectivity for Cu2+ is therefore due to its oxidation capability in CH3CN, which makes it differ from the other metal ions tested. Hence the herein reported N-acylhydrazones do not act as metal coordinating chemosensors but instead fluorescent chemodosimeters for Cu2+.

The high fluorescence enhancement factor of 3a upon the addition of Cu2+ in CH3CN shows great potential for application to the fluorescent sensing of Cu2+ at a low concentration level. The fluorescence of 3a (0.5 µM) in the presence of 0.5 equivalents of Cu2+ levels off rapidly within 2 min (Fig. S13). Fluorescence titration of 3a (0.5 µM) shows a linear response toward Cu2+ over 25.0 nM to 0.25 µM in CH3CN, with a detection limit of 3.5 nM (Fig. S14). The fluorescent sensing of Cu2+ by 3a in H2O–CH3CN solutions was also tested. The optimal conditions obtained for the assay (Fig. S15-S17) were to carry it out in a 20:80 (v/v) mixture of CH3CN and H2O at pH 7.2 (5 mM Tris-HCl buffer, 0.1 M KCl) after heating at 50 °C for 3 h. In this case the detection limit was 0.30 µM. The FEF was proportional to the Cu2+ concentration over 1.0–160 µM at a 3a concentration of 10 µM (Fig. 7). The fluorescence enhancement of 3a by Cu2+ was also found to be independent of the counter anions of the Cu2+ such as NO3, Cl, AcO, ClO4, and SO42− in aqueous CH3CN solutions (Fig. S18).


(a) Fluorescence spectra of 3a (10 µM) in a mixture of CH3CN and Tris-HCl (5 mM, pH 7.2, 0.1 M KCl) aqueous buffer solution (20/80, v/v) in the presence of increasing concentrations of Cu2+ and (b) linear response curve. The excitation wavelength was 283 nm.
Fig. 7 (a) Fluorescence spectra of 3a (10 µM) in a mixture of CH3CN and Tris-HCl (5 mM, pH 7.2, 0.1 M KCl) aqueous buffer solution (20/80, v/v) in the presence of increasing concentrations of Cu2+ and (b) linear response curve. The excitation wavelength was 283 nm.

The fluorescence of 3a in 80% H2O–CH3CN (v/v) was found to be hardly altered by the other metal ions tested: Co2+, Ni2+, Zn2+, Cd2+, Hg2+, Mg2+, Ca2+, and Ba2+. The selectivity for Cu2+ over these metal ions remains remarkably high and the FEF of Cu2+ is only slightly influenced by the addition of either 5 equivalents of each or all of the interference metal ions, Fig. 8. In aqueous solutions, however, the response reaction was substantially slowed down, likely due to the efficient hydration of Cu2+. Means of dehydrating Cu2+ and/or the stabilizing of Cu+ in aqueous solutions are expected to enhance the reaction to a reasonable level that might allow efficient aqueous phase assays. This is currently underway in this laboratory.


(a) Fluorescence enhancement factors of 3a with individual ions (2.5 mM) and (b) Relative fluorescence responses to Cu2+ (100 µM) plus interference metal ion (500 µM) in a mixture of CH3CN and Tris-HCl (5 mM, pH 7.2, 0.1 M KCl) aqueous buffer solution (20/80, v/v). “All” means the relative fluorescence response of 3a to Cu2+ (100 µM) plus all the interference metal ions tested, Co2+, Ni2+, Zn2+, Cd2+, Hg2+, Mg2+, Ca2+, and Ba2+ at 500 µM each.
Fig. 8 (a) Fluorescence enhancement factors of 3a with individual ions (2.5 mM) and (b) Relative fluorescence responses to Cu2+ (100 µM) plus interference metal ion (500 µM) in a mixture of CH3CN and Tris-HCl (5 mM, pH 7.2, 0.1 M KCl) aqueous buffer solution (20/80, v/v). “All” means the relative fluorescence response of 3a to Cu2+ (100 µM) plus all the interference metal ions tested, Co2+, Ni2+, Zn2+, Cd2+, Hg2+, Mg2+, Ca2+, and Ba2+ at 500 µM each.

Conclusions

Highly selective and dramatic enhancements by Cu2+ of the fluorescence in CH3CN and CH3CN–H2O of a variety of N-acylhydrazones were observed and were shown to result from an oxidative cyclization by Cu2+ of the originally nonfluorescent N-acylhydrazones to the highly fluorescent rigid 1,3,4-oxadiazoles. In agreement with this conclusion was the structured emission from the CH3CN solution of N-acylhydrazones and Cu2+. To the best of our knowledge, this is the first-set of reported chemodosimeters following an oxidative cyclization reaction that exhibits outstanding selectivity for Cu2+ with a dramatic fluorescence enhancement output. The chemodosimeters can be applied to sense Cu2+ at nanomolar levels in CH3CN. Both high selectivity and sensitivity over other metal ions tested were obtained in a 20:80 (v/v) mixture of CH3CN and Tris-HCl aqueous buffer solution, despite a much slower reaction rate. Although at the moment we are unable to set a structural limit for an N-acylhydrazone to be facilely oxidized by Cu2+, as all those reported here undergo efficient oxidation cyclization, we expect that this oxidative cyclization reaction could be taken as an alternative route to 1,3,4-oxadiazoles, efficient electron acceptors employed in optoelectronic materials.13 As redox reactions are easily made selective for a reductant or an oxidant and even made reversible, creating chemodosimeters following the redox reaction strategy illustrated here shall be of general applicability.

Experimental

Chemicals used for syntheses were commercially available. Solvents for spectral titrations were redistilled CH3CN and deionized water.

Absorption and fluorescence spectra were recorded on Varian Cary 300 spectrophotometer and Hitachi F-4500 fluorescence spectrophotometer, respectively. Solutions were measured in a 1 cm quartz cell. Fluorescence quantum yields were measured using quinine sulfate as a standard (0.546 in 0.5 M H2SO4). 1H NMR and 13C NMR were acquired on Bruker AV400 and Varian Unity+ 500 MHz NMR spectrometers. HRMS were obtained on a Micromass LCT spectrometer using methanol as the solvent. EPR experiments were carried out on a Bruker EMX-10/12 spectrometer.

All spectral titrations were carried out by keeping the sensor concentration constant while varying the metal ion concentration. Metal ions were used as their perchlorates. In the pH titration experiments, the solution pH was adjusted by dilute NaOH and HCl solutions that contained the same concentration of metal ion. Potassium chloride was employed to maintain solution ionic strength.

Preparation and characterization of 2–12 and 13.

2–12 were facilely synthesized from equimolar amounts of N-(substituted-benzoyl)hydrazine (2 mmol) with aldehyde or ketone (2 mmol) by a one-step reaction in ethanol, respectively. The mixture were refluxed for 3 h and then cooled down to room temperature. The crude products were isolated by filtration, and then recrystallized from absolute ethanol. New compounds were fully characterized by 1H NMR, 13C NMR, and HRMS.

13 was synthesized from 3 (2 mmol) with 5 equivalents of Cu(ClO4)2 (10 mmol) in CH3CN that were refluxed with stirring for 24 h, and then evaporated in vacuo. Aqueous ethylenediamine (1.0 mol L−1× 25 mL) solution was added and the solution was then extracted by ethyl acetate (3 × 20 mL). The combined organic layer was thoroughly washed with water (3 × 20 ml), dried over anhydrous Na2SO4, and then concentrated under vacuum, then purified by column chromatography on silica gel with ethyl acetate-petroleum ether (1:5) as eluent. 13 was fully characterized by 1H NMR, 13C NMR, and HRMS to confirm the occurrence of oxidative cyclization reaction.

N′-(2-Methoxybenzylidene)-4-ethoxybenzohydrazide (2a). 1H NMR (500 MHz, DMSO-d6, TMS): δ = 1.35 (t, 3H, J = 7.0 Hz), 3.87 (s, 3H), 4.09–4.13 (m, 2H), 7.02 (t, 3H, J = 8.0 Hz), 7.11 (d, 1H, J = 8.0 Hz), 7.41 (t, 1H, J = 7.5 Hz), 7.87 (d, 1H, J = 7.0 Hz), 7.92 (d, 2H, J = 8.5 Hz), 8.81 (s, 1H), 11.72 ppm (s, 1H); 13C NMR (125 MHz, DMSO-d6, TMS): δ = 14.4, 55.6, 63.3, 111.7, 113.9, 120.6, 122.4, 125.2, 125.3, 129.4, 131.2, 142.4, 157.6, 161.1, 162.2 ppm; HRMS (ESI): m/z: calcd for C17H19N2O3: 299.1396 [M + H+]; found: 299.1395 [M + H+].
N′-(2-Methoxybenzylidene)-4-methylbenzohydrazide (2b). 1H NMR (500 MHz, DMSO-d6, TMS): δ = 2.38 (s, 3H), 3.87 (s, 3H), 7.03 (t, 1H, J = 7.5 Hz), 7.11(d, 1H, J = 8.5 Hz), 7.33 (d, 2H, J = 8.0 Hz), 7.42 (t, 1H, J = 7.5 Hz), 7.85 (d, 2H, J = 8.0 Hz), 7.88 (d, 1H, J = 8.5 Hz), 8.82 (s, 1H), 11.78 ppm (s, 1H); 13C NMR (125 MHz, DMSO-d6, TMS): δ = 20.9, 55.5, 111.7, 120.6, 122.4, 125.4, 127.5, 128.8, 130.4, 131.3, 141.6, 142.9, 157.6, 162.7 ppm; HRMS (ESI): m/z: calcd for C16H17N2O2: 269.1290 [M + H+]; found 269.1295 [M + H+].
N′-(2-Methoxybenzylidene)benzohydrazide (2c). 1H NMR (500 MHz, DMSO-d6, TMS): δ = 3.87 (s, 3H), 7.04 (t, 1H, J = 7.5 Hz), 7.12 (d, 1H, J = 8.5 Hz), 7.43 (t, 1H, J = 7.5 Hz), 7.52 (t, 2H, J = 7.5 Hz), 7.59 (t, 1H, J = 7.0 Hz), 7.88 (d, 1H, J = 7.5 Hz), 7.93 (d, 2H, J = 7.5 Hz), 8.82 (s, 1H), 11.85 ppm (s, 1H); 13C NMR (125 MHz, DMSO-d6, TMS): δ = 55.5, 111.6, 120.6, 122.3, 125.4, 127.5, 128.3, 131.4, 131.5, 133.3, 143.2, 157.7, 162.9 ppm; HRMS (ESI): m/z: calcd for C15H15N2O2: 255.1134 [M + H+]; found 255.1141 [M + H+].
N′-(2-Methoxybenzylidene)-4-chlorobenzohydrazide (2d). 1H NMR (500 MHz, DMSO-d6, TMS): δ = 3.87 (s, 3H), 7.03 (t, 1H, J = 7.5 Hz), 7.12 (d, 1H, J = 8.0 Hz), 7.43 (t, 1H, J = 7.5 Hz), 7.61 (d, 2H, J = 8.0 Hz), 7.88 (d, 1H, J = 8.5 Hz), 7.96 (d, 2H, J = 8.5 Hz), 8.81 (s, 1H), 11.90 ppm (s, 1H); 13C NMR (125 MHz, DMSO-d6, TMS): δ = 55.5, 111.7, 120.6, 122.2, 125.4, 128.4, 129.4, 131.5, 132.0, 136.5, 143.5, 157.7, 161.8 ppm; HRMS (ESI): m/z: calcd for C15H14ClN2O2: 289.0744 [M + H+]; found 289.0754 [M + H+].
4-Ethoxy-N′-(furan-2-ylmethylene)benzohydrazide (3a). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.35 (t, 3H, J = 7.0 Hz), 4.11 (m, 2H), 6.64 (m, 1H), 6.91 (d, 1H, J = 3.2 Hz), 7.04 (d, 2H, J = 8.8 Hz), 7.85 (s, 1H), 7.87 (d, 2H, J = 8.8 Hz), 8.33 (s, 1H), 11.66 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.4, 63.3, 112.1, 113.1, 114.0, 125.1, 129.4, 136.9, 145.0, 149.5, 161.2, 162.4 ppm; HRMS (ESI): m/z: calcd for C14H15N2O3: 259.1083 [M + H+]; found 259.1077 [M + H+].
N′-(Furan-2-ylmethylene)-4-methylbenzohydrazide (3b). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 2.38 (s, 3H), 6.64 (s, 1H), 6.92 (s, 1H), 7.33 (d, 2H, J = 7.6 Hz), 7.81 (d, 2H, J = 7.6 Hz), 7.85 (s, 1H), 8.34 (s, 1H), 11.73 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 20.9, 112.1, 113.3, 127.5, 128.9, 130.4, 137.2, 141.7, 145.0, 149.4, 162.8 ppm; HRMS (ESI): m/z: calcd for C13H13N2O2: 229.0977 [M + H+]; found 229.0977 [M + H+].
N′-(Furan-2-ylmethylene)benzohydrazide (3c). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 6.65 (s, 1H), 6.94 (s, 1H), 7.53 (t, 2H, J = 6.4 Hz), 7.60 (t, 1H, J = 6.8 Hz), 7.86 (s, 1H), 7.90 (d, 2H, J = 7.2 Hz), 8.35 (s, 1H), 11.80 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 112.1, 113.4, 127.5, 128.4, 131.7, 133.3, 137.5, 145.1, 149.4, 163.0 ppm; HRMS (ESI): m/z: calcd for C12H11N2O2: 215.0821 [M + H+]; found 215.0819 [M + H+].
4-Chloro-N′-(furan-2-ylmethylene)benzohydrazide (3d). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 6.65 (m, 1H), 6.96 (d, 1H, J = 3.2 Hz), 7.62 (d, 2H, J = 8.4 Hz), 7.87 (s, 1H), 7.93 (d, 2H, J = 8.4 Hz), 8.34 (s, 1H), 11.86 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 112.1, 113.7, 128.5, 129.4, 132.0, 136.5, 137.7, 145.2, 149.3, 161.9 ppm; HRMS (ESI): m/z: calcd for C12H10ClN2O2: 249.0431 [M + H+]; found 249.0427 [M + H+].
4-Ethoxy-N′-(1-(furan-2-yl)ethylidene)benzohydrazide (4). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.35 (t, 3H, J = 7.0 Hz), 2.28 (s, 3H), 4.11 (m, 2H), 6.61 (m, 1H), 6.95 (s, 1H), 7.02 (d, 2H, J = 8.8 Hz), 7.80 (s, 1H), 7.86 (d, 2H, J = 8.8 Hz), 10.52 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 13.7, 14.5, 63.3, 111.2, 111.8, 113.8, 125.7, 129.9, 144.5, 145.1, 148.2, 151.8, 161.1 ppm; HRMS (ESI): m/z: calcd for C15H17N2O3: 273.1239 [M + H+]; found 273.1245 [M + H+].
N′-(2-Ethoxybenzylidene)-4-ethoxybenzohydrazide (5). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.34–1.41 (m, 6H), 4.09–4.15 (m, 4H), 7.00 (d, 1H, J = 7.6 Hz), 7.03 (d, 2H, J = 8.8 Hz), 7.09 (d, 1H, J = 8.0 Hz), 7.39 (t, 1H, J = 7.6 Hz), 7.88 (d, 1H, J = 7.6 Hz), 7.91 (d, 2H, J = 8.8 Hz), 8.80 (s, 1H), 11.75 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.5, 14.6, 63.3, 63.7, 112.7, 114.0, 120.6, 122.6, 125.2, 125.4, 129.5, 131.3, 142.5, 157.0, 161.2, 162.4 ppm; HRMS (ESI): m/z: calcd for C18H21N2O3: 313.1552 [M + H+]; found 313.1556 [M + H+].
N′-(2-Propoxybenzylidene)-4-ethoxybenzohydrazide (6). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.05 (t, 3H, J = 7.2 Hz), 1.36 (t, 3H, J = 7.2 Hz), 1.79 (m, 2H), 4.02 (t, 2H, J = 6.4 Hz), 4.11 (m, 2H), 6.99 (d, 1H, J = 7.2 Hz), 7.04 (d, 2H, J = 8.8 Hz), 7.08 (d, 1H, J = 8.4 Hz), 7.38 (m, 1H), 7.87 (s, 1H), 7.91 (d, 2H, J = 8.8 Hz), 8.80 (s, 1H), 11.76 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 10.5, 14.4, 22.0, 63.3, 69.4, 112.6, 113.9, 120.5, 122.6,125.3, 125.4, 129.5, 131.2, 142.4, 157.1, 161.1, 162.4 ppm; HRMS (ESI): m/z: calcd for C19H23N2O3: 327.1709 [M + H+]; found 327.1703 [M + H+].
N′-(2-Isopropoxybenzylidene)-4-ethoxybenzohydrazide (7). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.32 (d, 6H, J = 6.0 Hz), 1.36 (t, 3H, J = 6.8 Hz), 4.11 (m, 2H), 4.70 (m, 1H), 7.00 (t, 1H, J = 7.2 Hz), 7.03 (d, 2H, J = 8.8 Hz), 7.12 (d, 1H, J = 8.0 Hz), 7.37 (t, 1H, J = 8.0 Hz), 7.87 (d, 1H, J = 8.0 Hz), 7.91 (d, 2H, J = 8.8 Hz), 8.76 (s, 1H), 11.72 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.4, 21.8, 63.3, 70.4, 113.9, 114.5, 120.6, 123.6, 125.3, 125.6, 129.5, 131.1, 142.8, 156.0, 161.1, 162.3 ppm; HRMS (ESI): m/z: calcd for C19H23N2O3: 327.1709 [M + H+]; found 327.1705 [M + H+].
4-Ethoxy-N′-(thiophen-2-ylmethylene)benzohydrazide (8). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.35 (t, 3H, J = 6.8 Hz), 4.11 (m, 2H), 7.04 (d, 2H, J = 8.8 Hz), 7.14 (m, 1H), 7.45 (d, 1H, J = 3.2 Hz), 7.66 (d, 1H, J = 4.8 Hz), 7.88 (d, 2H, J = 8.8 Hz), 8.67 (s, 1H), 11.68 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.4, 63.3, 114.0, 125.1, 127.7, 128.6, 129.4, 130.5, 139.2, 142.2, 161.2, 162.3 ppm; HRMS (ESI): m/z: calcd for C14H15N2O2S: 275.0854 [M + H+]; found 275.0855 [M + H+].
N′-Benzylidene-4-ethoxybenzohydrazide (9). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.36 (t, 3H, J = 7.0 Hz), 4.09–4.14 (m, 2H), 7.05 (d, 2H, J = 8.8 Hz), 7.43–7.48 (m, 3H), 7.73 (d, 2H, J = 6.4 Hz), 7.91 (d, 2H, J = 8.8 Hz), 8.45 (s, 1H), 11.73 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.4, 63.3, 114.0, 125.2, 126.9, 128.7, 129.5, 129.8, 134.4, 147.0, 161.2, 162.5 ppm; HRMS (ESI): m/z: calcd for C16H17N2O2: 269.1290 [M + H+]; found 269.1289 [M + H+].
4-Ethoxy-N′-(2-methylpropylidene)benzohydrazide (10). 1H NMR (400 MHz, CD3CN): δ = 1.10 (d, 6H, J = 6.8 Hz), 1.38 (t, 3H, J = 7.0 Hz), 2.51–2.59 (m, 1H), 4.07–4.12 (m, 2H), 6.96 (d, 2H, J = 7.2 Hz), 7.51 (s, 1H), 7.77 (d, 2H, J = 8.4 Hz), 9.67 ppm (s, 1H); 13C NMR (400 MHz, DMSO-d6, TMS): δ = 14.4, 19.6, 31.0, 63.2, 113.9, 125.4, 129.3, 155.9, 161.0, 162.2 ppm; HRMS (ESI): m/z: calcd for C13H19N2O2: 235.1447 [M + H+]; found 235.1446 [M + H+].
4-Phenyl-N′-(2-methoxybenzylidene)benzohydrazide (11). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 3.88 (s, 3H), 7.05 (t, 1H, J = 7.6 Hz), 7.13 (d, 1H, J = 8.4 Hz), 7.43 (m, 2H), 7.52 (t, 2H, J = 7.6 Hz), 7.76 (d, 2H, J = 7.6 Hz), 7.84 (d, 2H, J = 8.4 Hz), 7.91 (d, 1H, J = 6.8 Hz), 8.05 (d, 2H, J = 8.4 Hz), 8.86 (s, 1H), 11.92 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 55.6, 111.8, 120.7, 122.3, 125.4, 126.6, 126.8, 128.1, 128.2, 129.0, 131.5, 132.0, 139.0, 143.1, 157.7, 162.5 ppm; HRMS (ESI): m/z: calcd for C21H19N2O2: 331.1447 [M + H+]; found 331.1451 [M + H+].
N′-(2-Methoxybenzylidene)-2-naphthohydrazide (12). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 3.89 (s, 3H), 7.06 (t, 1H, J = 7.2 Hz), 7.13 (d, 1H, J = 8.4 Hz), 7.45 (t, 1H, J = 7.6 Hz), 7.64 (m, 2H), 7.92 (d, 1H, J = 7.6 Hz), 8.01–8.09 (m, 4H), 8.58 (s, 1H), 8.88 (s, 1H), 12.03 ppm (s, 1H); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 55.6, 111.8, 120.7, 122.3, 124.2, 125.4, 126.8, 127.6, 127.8, 127.9, 128.0, 128.3, 130.6, 131.5, 132.0, 134.2, 143.1, 157.7, 162.8 ppm; HRMS (ESI): m/z: calcd for C19H17N2O2: 305.1290 [M + H+]; found 305.1281 [M + H+].
2-(4-Ethoxyphenyl)-5-furan-2-yl-1,3,4-oxadiazole (13a). 1H NMR (400 MHz, DMSO-d6, TMS): δ = 1.37 (t, 3H, J = 7.0 Hz), 4.14 (m, 2H), 6.83 (m, 1H), 7.16 (d, 2H, J = 8.8 Hz), 7.43 (d, 1H, J = 3.6 Hz), 8.00 (d, 2H, J = 8.8 Hz), 8.08 ppm (d, 1H, J = 1.2 Hz); 13C NMR (100 MHz, DMSO-d6, TMS): δ = 14.4, 63.5, 112.6, 114.4, 115.1, 115.2, 128.5, 138.6, 146.8, 156.4, 161.4, 163.1 ppm; HRMS (ESI): m/z: calcd for C14H13N2O3: 257.0926 [M + H+]; found 257.0927 [M + H+].
2-Furan-2-yl-5-p-tolyl-1,3,4-oxadiazole (13b). 1H NMR (400 MHz, CDCl3, TMS): δ = 2.44 (s, 3H), 6.62 (m, 1H), 7.23 (d, 1H, J = 3.2 Hz), 7.33 (d, 2H, J = 8.0 Hz), 7.67 (d, 1H, J = 1.2 Hz), 8.01 ppm (d, 2H, J = 8.0 Hz); 13C NMR (100 MHz, CDCl3, TMS): δ = 21.7, 112.2, 113.9, 120.8, 127.0, 129.8, 139.6, 142.5, 145.6, 157.4, 164.2 ppm; HRMS (ESI): m/z: calcd for C13H11N2O2: 227.0821 [M + H+]; found 227.0822 [M + H+].
2-Furan-2-yl-5-phenyl-1,3,4-oxadiazole (13c). 1H NMR (400 MHz, CDCl3, TMS): δ = 6.63 (m, 1H), 7.24 (d, 1H, J = 3.6 Hz), 7.52 (s, 1H), 7.54 (m, 2H), 7.67 (d, 1H, J = 1.2 Hz), 8.13 ppm (m, 2H); 13C NMR (100 MHz, CDCl3, TMS): δ = 112.2, 114.0, 123.5, 127.0, 129.0, 131.8, 139.4, 145.7, 157.4, 163.9 ppm; HRMS (ESI): m/z: calcd for C12H9N2O2: 213.0664 [M + H+]; found 213.0669 [M + H+].
2-(4-Chlorophenyl)-5-furan-2-yl-1,3,4-oxadiazole (13d). 1H NMR (400 MHz, CDCl3, TMS): δ = 6.63 (m, 1H), 7.25 (d, 1H, J = 3.6 Hz), 7.51(d, 2H, J = 8.8 Hz), 7.68 (t, 1H, J = 0.8 Hz), 8.06 ppm (d, 2H, J = 8.4 Hz); 13C NMR (100 MHz, CDCl3, TMS): δ = 112.2, 114.3, 122.0, 128.2, 129.5, 138.1, 139.3, 145.8, 157.5, 163.1 ppm; HRMS (ESI): m/z: calcd for C12H8ClN2O2: 247.0274 [M + H+]; found 247.0272 [M + H+].

Acknowledgements

This work was supported by the NSFC of China (20425518, 20675069), NFFTBS (J0630429), and the Ministry of Education (MOE) of China.

Notes and references

  1. (a) W. G. Skene and J. M. Lehn, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 8270–8275 CrossRef CAS; (b) O. Ramström, S. Lohmann, T. Bunyapaiboonsri and J. M. Lehn, Chem. Eur. J., 2004, 10, 1711–1715 CrossRef; (c) T. Ono, T. Nobori and J. M. Lehn, Chem. Commun., 2005, 1522–1524 RSC; (d) J. M. Lehn, Prog. Polym. Sci., 2005, 30, 814–831 CrossRef CAS; (e) M. Sugiura and S. Kobayashi, Angew. Chem., Int. Ed., 2005, 44, 5176–5186 CrossRef CAS; (f) G. K. Friestad, Eur. J. Org. Chem., 2005, 3157–3172 CrossRef CAS.
  2. (a) C.-Q. Jiang, B. Tang, R.-Y. Wang and J.-C. Yen, Talanta, 1997, 44, 197–202 CrossRef CAS; (b) B. Tang, F. Han and G.-Y. Zhang, Talanta, 2002, 56, 603–611 CrossRef CAS; (c) B. Tang, J. Zhang and Z.-Z. Chen, Spectrochim. Acta A, 2003, 59, 2519–2526 CrossRef; (d) Y. Xiang, A.-J. Tong, P.-Y. Jin and Y. Ju, Org. Lett., 2006, 8, 2863–2866 CrossRef CAS; (e) D.-Y. Wu, W. Huang, C.-Y. Duan, Z.-H. Lin and Q.-J. Meng, Inorg. Chem., 2007, 46, 1538–1540 CrossRef CAS; (f) Y. B. Wei and M. L. Guo, Angew. Chem., Int. Ed., 2007, 46, 4722–4725 CrossRef CAS.
  3. (a) N. R. Sangeetha, K. Baradi, R. Gupta, C. K. Pal, V. Manivannan and S. Pal, Polyhedron, 1999, 18, 1425–1429 CrossRef CAS; (b) Z.-Y. Yang, R.-D. Yang, F.-S. Li and K.-B. Yu, Polyhedron, 2000, 19, 2599–2604 CrossRef CAS; (c) Z. H. Chohan, Synth. React. Inorg. Met. Org. Chem., 2001, 31, 1–16 CrossRef CAS; (d) S. Choudhary and J. R. Morrow, Angew. Chem., Int. Ed., 2002, 41, 4096–4098 CrossRef CAS; (e) P. F. Lee, C.-T. Yang, D.-M. Fan, J. J. Vittal and J. D. Ranford, Polyhedron, 2003, 22, 2781–2786 CrossRef CAS; (f) L. K. Charkoudian, D. M. Pham and K. J. Franz, J. Am. Chem. Soc., 2006, 128, 12424–12425 CrossRef CAS; (g) J. Becher, I. Seidel, W. Plass and D. Klemm, Tetrahedron, 2006, 62, 5675–5681 CrossRef CAS.
  4. (a) A. P. de Silva, H. Q. N. Gunaratne, T. Gunnlaugsson, A. J. M. Huxley, C. P. McCoy, J. T. Rademacher and T. E. Rice, Chem. Rev., 1997, 97, 1515–1566 CrossRef; (b) B. Valeur and I. Leray, Coord. Chem. Rev., 2000, 205, 3–40 CrossRef; (c) J. S. Kim and D. T. Quang, Chem. Rev., 2007, 107, 3780–3799 CrossRef CAS.
  5. R. Krämer, Angew. Chem., Int. Ed., 1998, 37, 772–773 CrossRef CAS.
  6. Z.-C. Wen, R. Yang, H. He and Y -B. Jiang, Chem. Commun., 2006, 106–108 RSC.
  7. (a) P. Ghosh and P. K. Bharadwaj, J. Am. Chem. Soc., 1996, 118, 1553–1554 CrossRef CAS; (b) B. Ramachandram and A. Samanta, Chem. Commun., 1997, 1037–1038 RSC; (c) B. Ramachandram and A. Samanta, J. Phys. Chem. A, 1998, 102, 10579–10587 CrossRef CAS; (d) K. A. Mitchell, R. G. Brown, D. -W. Yuan, S. -C. Chang, R. E. Utecht and D. E. Lewis, J. Photochem. Photobiol. A, 1998, 115, 157–161 CrossRef CAS; (e) B. Ramachandram, G. Saroja, N. B. Sankaran and A. Samanta, J. Phys. Chem. B, 2000, 104, 11824–11832 CrossRef CAS; (f) K. Rurack, M. Kollmannsberger, U. Resch-Genger and J. Daub, J. Am. Chem. Soc., 2000, 122, 968–969 CrossRef CAS; (g) G. Hennrich, W. Walther, U. Resch-Genger and H. Sonnenschein, Inorg. Chem., 2001, 40, 641–644 CrossRef CAS; (h) J.-S. Yang, C.-S. Lin and C.-Y. Hwang, Org. Lett., 2001, 3, 889–892 CrossRef CAS; (i) S. Kaur and S. Kumar, Chem. Commun., 2002, 2840–2841 RSC; (j) Q.-Y. Wu and E. V. Anslyn, J. Am. Chem. Soc., 2004, 126, 14682–14683 CrossRef CAS; (k) M. Royzen, Z.-H. Dai and J. W. Canary, J. Am. Chem. Soc., 2005, 127, 1612–1613 CrossRef CAS; (l) Z.-C. Xu, Y. Xiao, X.-H. Qian, J.-N. Cui and D.-W. Cui, Org. Lett., 2005, 7, 889–892 CrossRef CAS; (m) B. Bag and P. K. Bharadwaj, Org. Lett., 2005, 7, 1573–1576 CrossRef CAS; (n) Z.-C. Xu, X.-H. Qian and J.-N. Cui, Org. Lett., 2005, 7, 3029–3032 CrossRef CAS; (o) R. Martínez, A. Espinosa, A. Tárraga and P. Molina, Org. Lett., 2005, 7, 5869–5872 CrossRef CAS; (p) R. Martínez, F. Zapata, A. Caballero, A. Espinosa, A. Tárraga and P. Molina, Org. Lett., 2006, 8, 3235–3238 CrossRef CAS; (q) H. Yang, Z.-Q. Liu, Z.-G. Zhou, E.-X. Shi, F.-Y. Li, Y.-K. Du, T. Yi and C.-H. Huang, Tetrahedron Lett., 2006, 47, 2911–2914 CrossRef CAS; (r) N. K. Singhal, B. Ramanujam, V. Mariappanadar and C. P. Rao, Org. Lett., 2006, 8, 3525–3528 CrossRef CAS; (s) J. W. Liu and Y. Lu, J. Am. Chem. Soc., 2007, 129, 9838–9839 CrossRef CAS; (t) X. Zhang, Y. Shiraishi and T. Hiral, Org. Lett., 2007, 9, 5039–5042 CrossRef CAS; (u) S. H. Choi, K. Pang, K. Kim and D. G. Churchill, Inorg. Chem., 2007, 46, 10564–10577 CrossRef CAS; (v) M. H. Lee, H. J. Kim, S. Yoon, N. Park and J. S. Kim, Org. Lett., 2008, 10, 213–216 CrossRef CAS; (w) H. J. Kim, J. Hong, A. Hong, S. Ham, J. H. Lee and J. S. Kim, Org. Lett., 2008, 10, 1963–1966 CrossRef CAS; (x) G.-K. Li, Z.-X. Xu, C. -F. Chen and Z.-T. Huang, Chem. Commun., 2008, 1774–1776 RSC.
  8. (a) V. Dujols, F. Ford and A. W. Czarnik, J. Am. Chem. Soc., 1997, 119, 7386–7387 CrossRef CAS; (b) R. M. Kierat and R. Krämer, Bioorg. Med. Chem. Lett., 2005, 15, 4824–4827 CrossRef CAS; (c) J. Kovács, T. Rödler and A. Mokhir, Angew. Chem., Int. Ed., 2006, 45, 7815–7817 CrossRef CAS; J. Kovács, T. Rödler and A. Mokhir, Angew. Chem., 2006, 118, 7979–7981 CrossRef; (d) X. Qi, E. J. Jun, L. Xu, S.-J. Kim, J. S. J. Hong, Y. J. Yoon and J. Yoon, J. Org. Chem., 2006, 71, 2881–2884 CrossRef CAS; (e) J. Kovács and A. Mokhir, Inorg. Chem., 2008, 47, 1880–1882 CrossRef CAS.
  9. J. L. Bricks, K. Rurack, R. Radeglia, G. Reck, B. Schulz, H. Sonnenschein and U. Resch-Genger, J. Chem. Soc. Perkin Trans. 2, 2000, 1209–1214 RSC.
  10. A. Mokhir and R. Krämer, Chem. Commun., 2005, 2244–2246 RSC.
  11. (a) T. Chiba and M. Okimoto, J. Org. Chem., 1992, 57, 1375–1379 CrossRef CAS; (b) R.-Y. Yang and L.-X. Dai, J. Org. Chem., 1993, 58, 3381–3383 CrossRef CAS; (c) S. Rostamizadeh and S. A. G. Housaini, Tetrahedron Lett., 2004, 45, 8753–8756 CrossRef CAS; (d) M. Dabiri, P. Salehi, M. Baghbanzadeh and M. Bahramnejad, Tetrahedron Lett., 2006, 47, 6983–6986 CrossRef CAS.
  12. (a) B. Kratochvil, D. A. Zatko and R. Markuszewski, Anal. Chem., 1966, 38, 770–772 CrossRef CAS; (b) B. Kratochvil and D. A. Zatko, Anal. Chem., 1968, 40, 422–424 CrossRef CAS; (c) D. A. Zatko and B. Kratochvil, Anal. Chem., 1968, 40, 2120–2123 CrossRef CAS; (d) M. Inamo, H. Kumagai, U. Harada, S. Itoh, S. Iwatsuki, K. Ishihara and H. D. Takagi, Dalton Trans., 2004, 11, 1703–1707 Search PubMed; (e) M. S. Rodríguez-Morgade, M. Planells, T. Torres, P. Ballester and E. Palomares, J. Mater. Chem., 2008, 18, 176–181 RSC.
  13. (a) C. Adachi, T. Tsutsui and S. Saito, Appl. Phys. Lett., 1990, 56, 799–801 CrossRef CAS; (b) A. R. Brown, D. D. C. Bradley, J. H. Burroughes, R. H. Friend, N. C. Greenham, P. L. Burn, A. B. Holmes and A. Kraft, Appl. Phys. Lett., 1992, 61, 2793–2795 CrossRef CAS; (c) W. L. Yu, H. Meng, J. Pei and W. Huang, J. Am. Chem. Soc., 1998, 120, 11808–11809 CrossRef CAS; (d) J. J. Kim, K. -S. Kim, S. Baek, H. C. Kim and M. Ree, J. Polym. Sci. Part A: Polym. Chem., 2002, 40, 1173–1183 CrossRef CAS; (e) K. T. Kamtekar, C.-S. Wang, S. Bettington, A. S. Batsanov, I. F. Perepichka, M. R. Bryce, J. H. Ahn, M. Rabinal and M. C. Petty, J. Mater. Chem., 2006, 16, 3823–3835 RSC; (f) K.-M. Yeh and Y. Chen, J. Polym. Sci. Part A: Polym. Chem., 2006, 44, 5362–5377 CrossRef CAS; (g) J. Seo, S. Kim, S. H. Gihm, C. R. Park and S. Y. Park, J. Mater. Chem., 2007, 17, 5052–5057 RSC.

Footnote

Electronic supplementary information (ESI) available: Absorption and fluorescence spectral titration traces and NMR spectra for compounds 2–13. See DOI: 10.1039/b811612a

This journal is © The Royal Society of Chemistry 2009
Click here to see how this site uses Cookies. View our privacy policy here.